News from orexigen therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 18, 2015, 09:00 ET

Orexigen Therapeutics to Speak at the JMP Securities Life Sciences Conference

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the JMP Securities...

Jun 05, 2015, 08:31 ET

Orexigen Announces Upcoming Data Presentations from the Open-Label Contrave® Ignite Study at the Annual Meeting of the American Diabetes Association

Orexigen Therapeutics (NASDAQ: OREX) announced today that two Contrave® (naltrexone HCI and bupropion HCI) abstracts will be presented at the...

Jun 05, 2015, 08:30 ET

Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that it and its North American partner, Takeda Pharmaceuticals, have filed a lawsuit in...

May 12, 2015, 19:19 ET

Orexigen Therapeutics Provides Statement on Termination of the Light Study and Updates on Contrave Collaboration with Takeda Pharmaceuticals

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today issued the following statement regarding the termination of the Light Study a cardiovascular...

May 12, 2015, 08:30 ET

Takeda Pharmaceuticals and Orexigen Therapeutics Announce Termination of the Cardiovascular Outcomes Study (Light Study) of the Obesity Drug Contrave® (naltrexone HCl and bupropion HCl)

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Development Center Americas, Inc. (Takeda) and Orexigen Therapeutics,...

May 08, 2015, 16:01 ET

Orexigen Therapeutics to Speak at the Bank of America Merrill Lynch Health Care Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a corporate overview at the 2015 Bank of America...

May 08, 2015, 07:00 ET

Orexigen Therapeutics Reports Financial and Business Results for the First Quarter Ended March 31, 2015

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the first quarter ended March 31, 2015. "We are...

May 05, 2015, 08:00 ET

Orexigen Therapeutics to Host First Quarter 2015 Financial Results Conference Call

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the first quarter 2015 on Friday, May 8 before the market...

Apr 22, 2015, 07:30 ET

Orexigen Announces Receipt of Paragraph IV Certification Notice

  Orexigen Therapeutics, Inc. (NASDAQ: OREX) today announced that Orexigen and North American partner Takeda Pharmaceuticals have received...

Apr 10, 2015, 16:01 ET

Orexigen Therapeutics to Speak at the Needham Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a corporate overview at the 2015 Needham Healthcare...

Mar 30, 2015, 08:45 ET

Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Tom Cannell has joined as Chief Commercial Officer. As the Company prepares...

Mar 26, 2015, 14:22 ET

Orexigen's Mysimba™ Approved in Europe for the Treatment of Obesity

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the European Commission has granted marketing authorization for Mysimba™...

Feb 25, 2015, 06:30 ET

Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the fourth quarter and year ended December 31,...

Feb 23, 2015, 08:30 ET

Orexigen Therapeutics to Speak at the 2015 RBC Capital Markets Global Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the 2015 RBC...

Feb 20, 2015, 16:45 ET

Orexigen Therapeutics to Host Full Year and Fourth Quarter 2014 Financial Results Conference Call and Webcast

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the fourth quarter and full year 2014 on Wednesday, February 25...

Feb 09, 2015, 08:00 ET

Orexigen Provides Progress Update on Mysimba European Marketing Authorization

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced an update on the European marketing authorization application (MAA) for...

Feb 06, 2015, 16:15 ET

Orexigen Therapeutics to Speak at the Leerink Global Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the...

Jan 08, 2015, 09:00 ET

Orexigen Therapeutics to Present at the J.P. Morgan 2015 Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the J.P. Morgan 2015...

Dec 19, 2014, 07:19 ET

Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union

 Orexigen Therapeutics (NASDAQ: OREX) announced today that the Committee for Medicinal Products For Human Use (CHMP) of the European Medicines...

Nov 26, 2014, 08:30 ET

Orexigen Therapeutics to Present at the Piper Jaffray Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Piper...